By Bhanvi Satija LONDON, April 12 (Reuters) - British drugmaker GSK's experimental targeted cancer drug Mo-rez has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

LONDON/PARIS, Dec 7 (Reuters) - Shares of GSK GSK.L and Sanofi SASY.PA surged in early trading on Wednesday, following the dismissal of thousands of U.S. lawsuits claiming that the heartburn drug ...

GSK’s planned investment of up to $800 million in its campus near Marietta got a $9 million boost from a state Redevelopment Capital Assistance Program grant earlier this year. The grant is part of ...

GSK has signed an eleventh-hour agreement to give Alfasigma rights to its primary biliary cholangitis (PBC) therapy linerixibat, which is under regulatory review in most major pharma markets worldwide ...

Good morning, everyone, and thanks for joining on day 3 of our Biopharma Innovation Summit. Very pleased to start the day this morning with a fireside chat with Kaivan Khavandi, who's Head of ...

March 19 (Reuters) - The U.S. Food and Drug Administration approved GSK's (GSK.L), opens new tab drug for severe itching caused by a type of liver disease, the company said on Thursday. The drug, ...

(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration approved Lynavoy for the treatment of cholestatic pruritus in patients with primary biliary cholangitis. The London-based ...